BATH & BODY WORKS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.29B | $7.31B | $7.43B | $7.56B | $7.88B | $6.43B | $5.41B | $13.24B |
| Cost of Revenue | $4.10B | $4.07B | $4.19B | $4.31B | $4.03B | $3.34B | $3.02B | $8.34B |
| Gross Profit | $3.19B | $3.23B | $3.24B | $3.26B | $3.86B | $3.10B | $2.39B | $4.90B |
| Gross Margin | 43.7% | 44.3% | 43.6% | 43.1% | 48.9% | 48.1% | 44.2% | 37.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.06B | $1.97B | $1.95B | $1.88B | $1.85B | $1.49B | $1.35B | $3.56B |
| Operating Income | $1.13B | $1.27B | $1.29B | $1.38B | $2.01B | $1.60B | $1.04B | $1.24B |
| Operating Margin | 15.4% | 17.3% | 17.3% | 18.2% | 25.5% | 24.9% | 19.2% | 9.3% |
| Interest Expense | $276.0M | $312.0M | $345.0M | $348.0M | $388.0M | $432.0M | $370.0M | $385.0M |
| Pretax Income | $882.0M | $1.03B | $1.02B | $1.05B | $1.42B | $1.12B | $608.0M | $857.0M |
| Income Tax Expense | $233.0M | $230.0M | $143.0M | $251.0M | $348.0M | $257.0M | $148.0M | $213.0M |
| Net Income | $649.0M | $798.0M | $878.0M | $800.0M | $1.33B | $844.0M | $-366.0M | $644.0M |
| Net Margin | 8.9% | 10.9% | 11.8% | 10.6% | 16.9% | 13.1% | -6.8% | 4.9% |
| EPS (Basic) | $3.12 | $3.62 | $3.86 | $3.45 | $4.96 | $3.04 | $-1.33 | $2.33 |
| EPS (Diluted) | $3.11 | $3.61 | $3.84 | $3.43 | $4.88 | $3.00 | $-1.32 | $2.31 |
| Shares Outstanding (Basic) | 208.0M | 220.0M | 228.0M | 232.0M | 269.0M | 278.0M | 276.0M | 276.0M |
| Shares Outstanding (Diluted) | 209.0M | 221.0M | 229.0M | 233.0M | 273.0M | 281.0M | 278.0M | 279.0M |
| Dividends Per Share | $0.80 | $0.80 | $0.80 | $0.80 | $0.45 | $0.30 | $1.20 | $2.40 |